Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Early readmissions after percutaneous coronary intervention in a rural tertiary care center (from the Guthrie Health Off-label Stent [GHOST] Registry).

Harjai KJ, Singh M, Boura J.

Am J Cardiol. 2012 Aug 15;110(4):491-7. doi: 10.1016/j.amjcard.2012.04.022. Epub 2012 May 11.

PMID:
22579345
2.

30-day readmission for patients undergoing percutaneous coronary interventions in New York state.

Hannan EL, Zhong Y, Krumholz H, Walford G, Holmes DR Jr, Stamato NJ, Jacobs AK, Venditti FJ, Sharma S, King SB 3rd.

JACC Cardiovasc Interv. 2011 Dec;4(12):1335-42. doi: 10.1016/j.jcin.2011.08.013.

3.

All-cause readmission and repeat revascularization after percutaneous coronary intervention.

Przybysz-Zdunek B, Ploch M, Pluta W, Dada M, Opolski G.

Cardiol J. 2012;19(2):174-9.

4.

Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.

Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K.

Thromb Haemost. 2010 Dec;104(6):1211-8. doi: 10.1160/TH10-04-0218. Epub 2010 Oct 12.

PMID:
20941464
5.

Low-dose versus high-dose aspirin after percutaneous coronary intervention: analysis from the guthrie health off-label StenT (GHOST) registry.

Harjai KJ, Shenoy C, Orshaw P, Usmani S, Singh M, Boura J, Mehta RH.

J Interv Cardiol. 2011 Aug;24(4):307-14. doi: 10.1111/j.1540-8183.2011.00627.x. Epub 2011 Jul 25.

PMID:
21790788
6.

Readmission in the 30 days after percutaneous coronary intervention.

Yost GW, Puher SL, Graham J, Scott TD, Skelding KA, Berger PB, Blankenship JC.

JACC Cardiovasc Interv. 2013 Mar;6(3):237-44. doi: 10.1016/j.jcin.2012.10.015.

7.

All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients.

Curtis JP, Schreiner G, Wang Y, Chen J, Spertus JA, Rumsfeld JS, Brindis RG, Krumholz HM.

J Am Coll Cardiol. 2009 Sep 1;54(10):903-7. doi: 10.1016/j.jacc.2009.04.076.

8.

Thirty-day readmission rates after PCI in a metropolitan center in Europe: incidence and impact on prognosis.

Moretti C, D'Ascenzo F, Omedè P, Sciuto F, Presutti DG, Di Cuia M, Colaci C, Giusto F, Ballocca F, Cerrato E, Colombo F, Gonella A, Giordana F, Longo G, Vilardi I, Bertaina M, Orlando A, Andrini R, Ferrando A, DiNicolantonio JJ, Zoccai GB, Sheiban I, Gaita F.

J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):238-45. doi: 10.2459/JCM.0000000000000136.

PMID:
25111771
9.

Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.

Mangiacapra F, Muller O, Ntalianis A, Trana C, Heyndrickx GR, Bartunek J, Vanderheyden M, Wijns W, De Bruyne B, Barbato E.

Am J Cardiol. 2010 Nov 1;106(9):1208-11. doi: 10.1016/j.amjcard.2010.06.044.

PMID:
21029814
10.

Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE Registry).

Caggegi A, Capodanno D, Capranzano P, Chisari A, Ministeri M, Mangiameli A, Ronsivalle G, Ricca G, Barrano G, Monaco S, Di Salvo ME, Tamburino C.

Am J Cardiol. 2011 Aug 1;108(3):355-9. doi: 10.1016/j.amjcard.2011.03.050. Epub 2011 May 3.

PMID:
21545992
11.

Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.

Marcucci R, Paniccia R, Antonucci E, Gori AM, Fedi S, Giglioli C, Valente S, Prisco D, Abbate R, Gensini GF.

Am J Cardiol. 2006 Nov 1;98(9):1156-9. Epub 2006 Aug 31.

PMID:
17056317
12.

Outcomes of drug-eluting stents for protected left main coronary artery disease (from the Multicenter, United States DEScover registry).

Leitner J, Vlachos HA, Selzer F, Jamal SM, Kip KE, Williams DO, Abbott JD.

Am J Cardiol. 2012 Feb 15;109(4):466-70. doi: 10.1016/j.amjcard.2011.09.038. Epub 2011 Nov 24.

PMID:
22118825
13.

Factors associated with 30-day readmission rates after percutaneous coronary intervention.

Khawaja FJ, Shah ND, Lennon RJ, Slusser JP, Alkatib AA, Rihal CS, Gersh BJ, Montori VM, Holmes DR, Bell MR, Curtis JP, Krumholz HM, Ting HH.

Arch Intern Med. 2012 Jan 23;172(2):112-7. doi: 10.1001/archinternmed.2011.569. Epub 2011 Nov 28.

14.

Major adverse noncardiac events after PCI as predictors of long-term mortality.

Harjai K, Shenoy C, Raizada A, Eswaran M, Acharji S, Sattur S, Orshaw P, Devarakonda S.

J Interv Cardiol. 2008 Oct;21(5):395-402. doi: 10.1111/j.1540-8183.2008.00387.x. Epub 2008 Aug 13.

PMID:
18705635
15.
16.
18.

Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.

Takagi K, Ielasi A, Shannon J, Latib A, Godino C, Davidavicius G, Mussardo M, Ferrarello S, Figini F, Carlino M, Montorfano M, Chieffo A, Nakamura S, Colombo A.

Circ Cardiovasc Interv. 2012 Aug 1;5(4):491-8. doi: 10.1161/CIRCINTERVENTIONS.111.964874. Epub 2012 Jul 31.

19.

Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.

Kornowski R, Mehran R, Dangas G, Nikolsky E, Assali A, Claessen BE, Gersh BJ, Wong SC, Witzenbichler B, Guagliumi G, Dudek D, Fahy M, Lansky AJ, Stone GW; HORIZONS-AMI Trial Investigators.

J Am Coll Cardiol. 2011 Aug 9;58(7):704-11. doi: 10.1016/j.jacc.2011.02.071.

20.

Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.

Novack V, Tsyvine D, Cohen DJ, Pencina M, Dubin J, Dehghani H, Kleiman NS, Cutlip DE.

Catheter Cardiovasc Interv. 2009 Jun 1;73(7):874-80. doi: 10.1002/ccd.21925.

PMID:
19180665

Supplemental Content

Support Center